Biomarker Technologies Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027

The Biomarker Technologies Market size is expected to grow at an annual average of 12% during 2021-2027. A biomarker is a biological property that is measured and evaluated as a generator of a normal biological or pathological process or in response to a therapeutic intervention. For example, gene expression patterns are used to identify various diseases. There are a variety of biomarkers that can be identified using a variety of techniques such as polymerase chain reaction, next-generation sequencing, immunoassays, and more. Biomarkers are widely used in the diagnosis of various diseases, such as cancer, infectious diseases, and autoimmune diseases. This is due to the properties that mark the biological changes associated with these diseases. Biomarkers are also used during drug development because they can indicate drug-related early toxicity at an early stage in drug development. Biomarkers are also used in personalized medicine because they provide sensitive data related to disease progression.

The following segmentation are covered in this report:

By Indication

• Cancer
• Infectious Diseases
• Autoimmune Disorders
• Cardiovascular Disorders
• Others

By Technology

• Polymerase Chain Reaction (PCR)
• Next Generation Sequencing (NGS)
• Immunoassay
• Others

By Application

• Drug Discovery
• Diagnostics
• Personalized Medicine

Company Profile

• AGILENT TECHNOLOGIES, INC.
• BIO-RAD LABORATORIES, INC.
• F. HOFFMANN-LA ROCHE LTD.
• Illumina, Inc.
• LI-COR, Inc.
• Merck KGAA
• PERKINELMER INC.
• QIAGEN N.V.
• Shimadzu Corporation
• Thermo Fisher Scientific, Inc.

Scope of the report

The research study analyses the Biomarker Technologies Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Biomarker Technologies Market Report

• What was the Biomarker Technologies Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Biomarker Technologies Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.